Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography

Ji Hwan Lee, Byunghoon Chung, Sungchul Lee, Sung Soo Kim, Hyoung Jun Koh, Christopher Seungkyu Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: To evaluate the incidence and risk factors of contrast-induced nephropathy (CIN) in patients undergoing fluorescein angiography (FA). Methods: One hundred sixty patients who underwent FA as a part of ophthalmic examination and had serum creatinine (SCr) results within 24 h before FA and within 72 h after FA between 2005 and 2013 at a tertiary medical center were included. According to baseline SCr levels, the subjects were divided into low-risk group (<1.5 mg/dL), intermediate-risk group (1.5-2.0 mg/dL), and high-risk group (>2.0 mg/dL) for CIN development. The CIN incidence, and changes in renal function defined by SCr levels and estimated glomerular filtration rate (eGFR) were evaluated. Demographics and comorbidities were analyzed to investigate an association with CIN development. Results: Of 160 patients, 91 were males (56.9%). The mean age was 52.46 ± 17.81 years. Two (1.3%) patients developed CIN after FA, whose SCr levels returned to normal within 10 days without hemodialysis. Overall, there were no changes before and after FA in SCr level (1.52 ± 1.31 mg/dL vs. 1.51 ± 1.28 mg/dL, respectively; p = 0.93) and eGFR (67.02 ± 36.62 mL/min/1.73 m2 vs. 66.41 ± 36.54 mL/min/1.73 m2, respectively; p = 0.54). SCr level and eGFR remained unchanged after FA in low-risk and intermediate-risk groups. In high-risk group, eGFR remined unchanged, but SCr level decreased after FA (from 3.64 ± 1.59 mg/dL to 3.53 ± 1.60 mg/dL; p = 0.04). Basline SCr and cormorbidities did not predict CIN development. Conclusions: Acute renal function deterioration was not evident in patients undergoing FA regardless of baseline renal function and comorbidities.

Original languageEnglish
Article number46
JournalBMC Ophthalmology
Volume17
Issue number1
DOIs
Publication statusPublished - 2017 Apr 19

Fingerprint

Fluorescein Angiography
Angiography
Creatinine
Incidence
Serum
Glomerular Filtration Rate
Kidney
Comorbidity
Renal Dialysis
Demography

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Lee, Ji Hwan ; Chung, Byunghoon ; Lee, Sungchul ; Kim, Sung Soo ; Koh, Hyoung Jun ; Lee, Christopher Seungkyu. / Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography. In: BMC Ophthalmology. 2017 ; Vol. 17, No. 1.
@article{5b35df2f7a1c4af98ae7bc3751af6bbf,
title = "Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography",
abstract = "Background: To evaluate the incidence and risk factors of contrast-induced nephropathy (CIN) in patients undergoing fluorescein angiography (FA). Methods: One hundred sixty patients who underwent FA as a part of ophthalmic examination and had serum creatinine (SCr) results within 24 h before FA and within 72 h after FA between 2005 and 2013 at a tertiary medical center were included. According to baseline SCr levels, the subjects were divided into low-risk group (<1.5 mg/dL), intermediate-risk group (1.5-2.0 mg/dL), and high-risk group (>2.0 mg/dL) for CIN development. The CIN incidence, and changes in renal function defined by SCr levels and estimated glomerular filtration rate (eGFR) were evaluated. Demographics and comorbidities were analyzed to investigate an association with CIN development. Results: Of 160 patients, 91 were males (56.9{\%}). The mean age was 52.46 ± 17.81 years. Two (1.3{\%}) patients developed CIN after FA, whose SCr levels returned to normal within 10 days without hemodialysis. Overall, there were no changes before and after FA in SCr level (1.52 ± 1.31 mg/dL vs. 1.51 ± 1.28 mg/dL, respectively; p = 0.93) and eGFR (67.02 ± 36.62 mL/min/1.73 m2 vs. 66.41 ± 36.54 mL/min/1.73 m2, respectively; p = 0.54). SCr level and eGFR remained unchanged after FA in low-risk and intermediate-risk groups. In high-risk group, eGFR remined unchanged, but SCr level decreased after FA (from 3.64 ± 1.59 mg/dL to 3.53 ± 1.60 mg/dL; p = 0.04). Basline SCr and cormorbidities did not predict CIN development. Conclusions: Acute renal function deterioration was not evident in patients undergoing FA regardless of baseline renal function and comorbidities.",
author = "Lee, {Ji Hwan} and Byunghoon Chung and Sungchul Lee and Kim, {Sung Soo} and Koh, {Hyoung Jun} and Lee, {Christopher Seungkyu}",
year = "2017",
month = "4",
day = "19",
doi = "10.1186/s12886-017-0440-4",
language = "English",
volume = "17",
journal = "BMC Ophthalmology",
issn = "1471-2415",
publisher = "BioMed Central",
number = "1",

}

Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography. / Lee, Ji Hwan; Chung, Byunghoon; Lee, Sungchul; Kim, Sung Soo; Koh, Hyoung Jun; Lee, Christopher Seungkyu.

In: BMC Ophthalmology, Vol. 17, No. 1, 46, 19.04.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography

AU - Lee, Ji Hwan

AU - Chung, Byunghoon

AU - Lee, Sungchul

AU - Kim, Sung Soo

AU - Koh, Hyoung Jun

AU - Lee, Christopher Seungkyu

PY - 2017/4/19

Y1 - 2017/4/19

N2 - Background: To evaluate the incidence and risk factors of contrast-induced nephropathy (CIN) in patients undergoing fluorescein angiography (FA). Methods: One hundred sixty patients who underwent FA as a part of ophthalmic examination and had serum creatinine (SCr) results within 24 h before FA and within 72 h after FA between 2005 and 2013 at a tertiary medical center were included. According to baseline SCr levels, the subjects were divided into low-risk group (<1.5 mg/dL), intermediate-risk group (1.5-2.0 mg/dL), and high-risk group (>2.0 mg/dL) for CIN development. The CIN incidence, and changes in renal function defined by SCr levels and estimated glomerular filtration rate (eGFR) were evaluated. Demographics and comorbidities were analyzed to investigate an association with CIN development. Results: Of 160 patients, 91 were males (56.9%). The mean age was 52.46 ± 17.81 years. Two (1.3%) patients developed CIN after FA, whose SCr levels returned to normal within 10 days without hemodialysis. Overall, there were no changes before and after FA in SCr level (1.52 ± 1.31 mg/dL vs. 1.51 ± 1.28 mg/dL, respectively; p = 0.93) and eGFR (67.02 ± 36.62 mL/min/1.73 m2 vs. 66.41 ± 36.54 mL/min/1.73 m2, respectively; p = 0.54). SCr level and eGFR remained unchanged after FA in low-risk and intermediate-risk groups. In high-risk group, eGFR remined unchanged, but SCr level decreased after FA (from 3.64 ± 1.59 mg/dL to 3.53 ± 1.60 mg/dL; p = 0.04). Basline SCr and cormorbidities did not predict CIN development. Conclusions: Acute renal function deterioration was not evident in patients undergoing FA regardless of baseline renal function and comorbidities.

AB - Background: To evaluate the incidence and risk factors of contrast-induced nephropathy (CIN) in patients undergoing fluorescein angiography (FA). Methods: One hundred sixty patients who underwent FA as a part of ophthalmic examination and had serum creatinine (SCr) results within 24 h before FA and within 72 h after FA between 2005 and 2013 at a tertiary medical center were included. According to baseline SCr levels, the subjects were divided into low-risk group (<1.5 mg/dL), intermediate-risk group (1.5-2.0 mg/dL), and high-risk group (>2.0 mg/dL) for CIN development. The CIN incidence, and changes in renal function defined by SCr levels and estimated glomerular filtration rate (eGFR) were evaluated. Demographics and comorbidities were analyzed to investigate an association with CIN development. Results: Of 160 patients, 91 were males (56.9%). The mean age was 52.46 ± 17.81 years. Two (1.3%) patients developed CIN after FA, whose SCr levels returned to normal within 10 days without hemodialysis. Overall, there were no changes before and after FA in SCr level (1.52 ± 1.31 mg/dL vs. 1.51 ± 1.28 mg/dL, respectively; p = 0.93) and eGFR (67.02 ± 36.62 mL/min/1.73 m2 vs. 66.41 ± 36.54 mL/min/1.73 m2, respectively; p = 0.54). SCr level and eGFR remained unchanged after FA in low-risk and intermediate-risk groups. In high-risk group, eGFR remined unchanged, but SCr level decreased after FA (from 3.64 ± 1.59 mg/dL to 3.53 ± 1.60 mg/dL; p = 0.04). Basline SCr and cormorbidities did not predict CIN development. Conclusions: Acute renal function deterioration was not evident in patients undergoing FA regardless of baseline renal function and comorbidities.

UR - http://www.scopus.com/inward/record.url?scp=85018485642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018485642&partnerID=8YFLogxK

U2 - 10.1186/s12886-017-0440-4

DO - 10.1186/s12886-017-0440-4

M3 - Article

C2 - 28420348

AN - SCOPUS:85018485642

VL - 17

JO - BMC Ophthalmology

JF - BMC Ophthalmology

SN - 1471-2415

IS - 1

M1 - 46

ER -